Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LDRT”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Early research (Phase 1)Study completedNCT03812549
What this trial is testing

Safety and Tolerability Evaluation of Sintilimab in Combination With Radiation in Stage IV NSCLC Patients

Who this might be right for
Stage IV NSCLC
Sichuan University 29
Testing effectiveness (Phase 2)Looking for participantsNCT07312422
What this trial is testing

LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study

Who this might be right for
Pancreatic CancerPD-L1PD-1 Inhibitor+2 more
Zhejiang Provincial People's Hospital 10
Testing effectiveness (Phase 2)Looking for participantsNCT06217757
What this trial is testing

Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC

Who this might be right for
Lung CancerExtensive-stage Small-cell Lung Cancer
Sichuan University 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT05092412
What this trial is testing

Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC

Who this might be right for
Lung CancerExtensive-stage Small-cell Lung CancerDurvalumab
You Lu 30
Not applicableNot Yet RecruitingNCT06969820
What this trial is testing

Establishment and Evaluation of Standardized Clinical, Biological and Imaging Parameters to Assess the Response of LDRT in Heel Spur With Plantar Fasciitis

Who this might be right for
Calcaneal Spur
University of Erlangen-Nürnberg Medical School 35
Testing effectiveness (Phase 2)WithdrawnNCT06331585
What this trial is testing

Effect of Low-dose Radiotherapy on Tumor Immune Microenvironment in Oligometastases of NSCLC After Immunotherapy

Who this might be right for
Low-dose RadiotherapyTumor MicroenvironmentNon-Small Cell Lung Cancer
Hetian District People's Hospital
Testing effectiveness (Phase 2)Looking for participantsNCT07325539
What this trial is testing

LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC

Who this might be right for
Nasopharyngeal Cancinoma (NPC)Nasopharangeal Cancer
Sun Yat-sen University 55
Early research (Phase 1)Looking for participantsNCT06349837
What this trial is testing

Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors

Who this might be right for
Solid Tumor
Sichuan University 24
Not applicableLooking for participantsNCT05887284
What this trial is testing

Investigation of the Clinical Efficacy of Low-dose Ionizing Radiation in the Treatment of Osteoarthritis

Who this might be right for
ArthrosisOsteoarthritis
University of Erlangen-Nürnberg Medical School 132
Testing effectiveness (Phase 2)Looking for participantsNCT06323239
What this trial is testing

SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 148
Early research (Phase 1)Looking for participantsNCT06848465
What this trial is testing

LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis

Who this might be right for
Colorectal CancerLiver MetastasisLDRT
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT05765825
What this trial is testing

Study of Low-Dose Radiotherapy Concurrent Chemotherapy With Serplulimab for Patients With ES-SCLC

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Sichuan University 61
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06266871
What this trial is testing

SOX Combined With Tislelizumab and LDRT for Neoadjuvant Treatment of Locally Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
West China Hospital 64
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06426654
What this trial is testing

Sintilimab Combined With LDRT for Neoadjuvant Treatment of Locally Advanced dMMR/MSI-H Gastric Cancer

Who this might be right for
Gastric Cancer
West China Hospital 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT06477523
What this trial is testing

Phase 1b/2 Study of LDRT in Combination With AK104 Plus Chemotherapy as First-line Treatment for ES-SCLC

Who this might be right for
SCLC, Extensive Stage
Sichuan University 57
Testing effectiveness (Phase 2)Looking for participantsNCT06121505
What this trial is testing

Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung Cancer

Who this might be right for
Lung Squamous Cell Carcinoma
Sichuan University 114
Testing effectiveness (Phase 2)Active Not RecruitingNCT06940921
What this trial is testing

SBRT-LDRT-Cadonilimab for Advanced Gastric, Colorectal and Ovarian Cancers With Peritoneal Metastases

Who this might be right for
Advanced Gastric CancerAdvanced Colorectal CancerAdvanced Ovarian Cancer+1 more
Zhang Tao 26
Early research (Phase 1)WithdrawnNCT06732258
What this trial is testing

Low-dose Radiotherapy Combined With Concurrent Chemotherapy, Toripalimab and Tifcemalimab in the Treatment of ES-SCLC

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Sichuan University
Not applicableLooking for participantsNCT02653079
What this trial is testing

Immunophenotyping From Blood of Patients Suffering From Chronic Degenerating Joint Diseases and Receiving LDRT

Who this might be right for
Chronic Inflammatory Disorder
University of Erlangen-Nürnberg Medical School 250
Testing effectiveness (Phase 2)UnknownNCT04878107
What this trial is testing

SBRT/LDRT in Combination With Camrelizumab and Apatinib in Metastatic Non-small Cell Lung Cancer Patient Previously Treated With PD-1/L1 Inhibitor and Chemotherapy

Who this might be right for
Non-Small Cell Lung Cancer
Wuhan University 88
Load More Results